Sökning: onr:"swepub:oai:gup.ub.gu.se/320594" > International compa...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05958naa a2201141 4500 | |
001 | oai:gup.ub.gu.se/320594 | |
003 | SwePub | |
008 | 240910s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3205942 URI |
024 | 7 | a https://doi.org/10.1111/dme.147662 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Prigge, R.4 aut |
245 | 1 0 | a International comparison of glycaemic control in people with type 1 diabetes: an update and extension |
264 | c 2021-12-26 | |
264 | 1 | b Wiley,c 2022 |
520 | a Aims: To update and extend a previous cross-sectional international comparison of glycaemic control in people with type 1 diabetes. Methods: Data were obtained for 520,392 children and adults with type 1 diabetes from 17 population and five clinic-based data sources in countries or regions between 2016 and 2020. Median HbA1c(IQR) and proportions of individuals with HbA1c < 58mmol/mol (<7.5%), 58–74mmol/mol (7.5–8.9%) and ≥75mmol/mol (≥9.0%) were compared between populations for individuals aged <15, 15–24 and ≥25 years. Logistic regression was used to estimate the odds ratio (OR) of HbA1c < 58mmol/mol (<7.5%) relative to ≥58mmol/mol (≥7.5%), stratified and adjusted for sex, age and data source. Where possible, changes in the proportion of individuals in each HbA1c category compared to previous estimates were calculated. Results: Median HbA1c varied from 55 to 79mmol/mol (7.2 to 9.4%) across data sources and age groups so a pooled estimate was deemed inappropriate. OR (95% CI) for HbA1c< 58mmol/mol (<7.5%) were 0.91 (0.90–0.92) for women compared to men, 1.68 (1.65–1.71) for people aged <15years and 0.81 (0.79–0.82) aged15–24years compared to those aged ≥25years. Differences between populations persisted after adjusting for sex, age and data source. In general, compared to our previous analysis, the proportion of people with an HbA1c<58mmol/l (<7.5%) increased and proportions of people with HbA1c≥ 75mmol/mol (≥9.0%) decreased. Conclusions: Glycaemic control of type 1 diabetes continues to vary substantially between age groups and data sources. While some improvement over time has been observed, glycaemic control remains sub-optimal for most people with Type 1 diabetes. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
653 | a glycaemic control | |
653 | a HbA1c | |
653 | a registers of people with diabetes | |
653 | a type 1 diabetes | |
653 | a glycosylated hemoglobin | |
653 | a adult | |
653 | a child | |
653 | a cross-sectional study | |
653 | a female | |
653 | a glucose blood level | |
653 | a glycemic control | |
653 | a human | |
653 | a insulin dependent diabetes mellitus | |
653 | a male | |
653 | a Blood Glucose | |
653 | a Cross-Sectional Studies | |
653 | a Diabetes Mellitus | |
653 | a Type 1 | |
653 | a Glycated Hemoglobin A | |
653 | a Humans | |
700 | 1 | a McKnight, J. A.4 aut |
700 | 1 | a Wild, S. H.4 aut |
700 | 1 | a Haynes, A.4 aut |
700 | 1 | a Jones, T. W.4 aut |
700 | 1 | a Davis, E. A.4 aut |
700 | 1 | a Rami-Merhar, B.4 aut |
700 | 1 | a Fritsch, M.4 aut |
700 | 1 | a Prchla, C.4 aut |
700 | 1 | a Lavens, A.4 aut |
700 | 1 | a Doggen, K.4 aut |
700 | 1 | a Chao, S.4 aut |
700 | 1 | a Aronson, R.4 aut |
700 | 1 | a Brown, R.4 aut |
700 | 1 | a Ibfelt, E. H.4 aut |
700 | 1 | a Svensson, J.4 aut |
700 | 1 | a Young, R.4 aut |
700 | 1 | a Warner, J. T.4 aut |
700 | 1 | a Robinson, H.4 aut |
700 | 1 | a Laatikainen, T.4 aut |
700 | 1 | a Rautiainen, P.4 aut |
700 | 1 | a Delemer, B.4 aut |
700 | 1 | a Souchon, P. F.4 aut |
700 | 1 | a Diallo, A. M.4 aut |
700 | 1 | a Holl, R. W.4 aut |
700 | 1 | a Schmid, S. M.4 aut |
700 | 1 | a Raile, K.4 aut |
700 | 1 | a Tigas, S.4 aut |
700 | 1 | a Bargiota, A.4 aut |
700 | 1 | a Zografou, I.4 aut |
700 | 1 | a Luk, A. O. Y.4 aut |
700 | 1 | a Chan, J. C. N.4 aut |
700 | 1 | a Dinneen, S. F.4 aut |
700 | 1 | a Buckley, C. M.4 aut |
700 | 1 | a Kgosidialwa, O.4 aut |
700 | 1 | a Cherubini, V.4 aut |
700 | 1 | a Gesuita, R.4 aut |
700 | 1 | a Strele, I.4 aut |
700 | 1 | a Pildava, S.4 aut |
700 | 1 | a Veeze, H.4 aut |
700 | 1 | a Aanstoot, H. J.4 aut |
700 | 1 | a Mul, D.4 aut |
700 | 1 | a Jefferies, C.4 aut |
700 | 1 | a Cooper, J. G.4 aut |
700 | 1 | a Løvaas, K. F.4 aut |
700 | 1 | a Battelino, T.4 aut |
700 | 1 | a Dovc, K.4 aut |
700 | 1 | a Bratina, N.4 aut |
700 | 1 | a Eeg-Olofsson, Katarina,d 1968u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xeegka |
700 | 1 | a Svensson, Ann-Marie,d 1961u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xsannh |
700 | 1 | a Gudbjörnsdottir, Soffia,d 1962u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xgudso |
700 | 1 | a Globa, E.4 aut |
700 | 1 | a Zelinska, N.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för medicin, avdelningen för molekylär och klinisk medicin4 org |
773 | 0 | t Diabetic Medicined : Wileyg 39:5q 39:5x 0742-3071x 1464-5491 |
856 | 4 8 | u https://gup.ub.gu.se/publication/320594 |
856 | 4 8 | u https://doi.org/10.1111/dme.14766 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy